產(chǎn)品詳情
簡(jiǎn)單介紹:
GSK-106hydrochloride
詳情介紹:
Characteristics |
PubChem CID: N/A Salt form: No GSK-106 is a useful negative control for PAD4 inhibitors (GSK-121 and GSK-484). It does not inhibit PAD4 nor does it prevent the citrullination of PAD4 target proteins or the formation of neutrophil extracellular traps in mouse or human neutrophils (IC??s > 100 μM). Smiles: O=C(N1CC(N)CCC1)C2=CC=C3C(N(C)C(C(N4CC)=CC5=C4C=CC=C5)=N3)=C2.[H]Cl InChi: InChI=1S/C24H27N5O.ClH/c1-3-29-20-9-5-4-7-16(20)13-22(29)23-26-19-11-10-17(14-21(19)27(23)2)24(30)28-12-6-8-18(25)15-28,/h4-5,7,9-11,13-14,18H,3,6,8,12,15,25H2,1-2H3,1H Inchi Key: VRPFLFUQMWOJAT-UHFFFAOYSA-N |
Purity | ≥ 98?% |
Chemical Name | (3-Aminopiperidin-1-yl)(2-(1-ethyl-1H-indol-2-yl)-1-methyl-1H-benzo[d]imidazol-6-yl)methanone hydrochloride |
Formula | C??H??ClN?O |
Permeability | Cell-permeable |
Background | Synonyms: (3-Aminopiperidin-1-yl)(2-(1-ethyl-1H-indol-2-yl)-1-methyl-1H-benzo[d]imidazol-6-yl)methanone hydrochloride |
Molecular Weight | 437.97 g/mol |
CAS-No | 1652591-82-6 |
Restrictions | For Research Use only |
Format | Solid |
Handling Advice | Protect from air and moisture |
Storage | -20 °C |
Expiry Date | 36 months |